Meanwhile, the patient presented progression of prostate cancer with increasing values of prostate specific antigen (PSA) since June 2024 from 24 ng/mL up to 93 ng/mL in October 2024 (normal value < 3.1 ng/mL). The gene discussed is KLK3; the disease is prostate carcinoma.